3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma
3
Prostatic Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Head and Neck Neoplasms
2
Uterine Cervical Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Gallbladder Neoplasms
1
Extensive Stage Small Cell Lung Carcinoma
1
Epstein-Barr Virus Infections
1
Carcinoma, Squamous Cell
1
Advanced Glioblastoma
1
Interventions
Gemcitabine
5
Cisplatin
5
Oxaliplatin
2
pertuzumab
1
durvalumab
1
Trastuzumab
1
Standard of Care
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Lymph Node Excision
1
Laparoscopy
1
Geriatric Assessment
1
Everolimus
1
Drug Therapy
1
Chemoradiotherapy
1
Capecitabine
1
ARRY-334543
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Gallbladder Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT02867865
2025-03-13
POLCAGB
Tata Memorial Hospital
Phase 2/3
Active not recruiting
124 enrolled